ONCOLOGY Vol 40, Issue 6

Drs Kathleen Moore, Ritu Salani, Casey Cosgrove, and Ebony Hoskins discussed how to use biomarkers to strategically select the most effective therapy for unique cases of endometrial cancer.

Experts split into 2 teams and discussed the latest data, pressing questions, and clinical scenarios regarding CAR T-cell therapy in diffuse large B-cell lymphoma.

ASCO 2026 spotlights practice-changing phase 3 results: daraxonrasib boosts pancreatic cancer survival, plus major advances in lung, prostate, sarcoma, and breast care.

Explore modern metastatic breast cancer care: longer survival, smarter symptom control, caregiver support, and steps to close racial treatment gaps.

This cross-sectional study evaluated the genetic landscape of a cohort of patients with metastatic prostate cancer who were treated at a referral center in Mexico City, Mexico.

Nathan Goodyear, MD, explained why exercise must be treated as a precise, prescribable therapy in oncology to combat AEs and improve long-term survival.